Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

2-PAT

SKU: orb1744092

Description

2-PAT is a reversible inhibitor of monoamine oxidase A (MAO-A) with an IC50 of 0.721 µM and an inactivator of MAO-B (IC50 = 14.6 µM). This small molecule, structurally related to Rasagiline and Selegiline, is a research tool for investigating Parkinson's disease and depression in biochemical and cellular assays.

Research Area

Neuroscience

Images & Validation

Key Properties

CAS Number134467-58-6
MW185.26
FormulaC13H15N
SMILESN(CC#C)C1CC=2C(CC1)=CC=CC2
TargetMonoamine Oxidase,Others

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • Human CL3L1 protein (Active) [orb359067]

    > 97% as determined by SDS-PAGE and HPLC.

    7.8 kDa

    E.Coli

    500 μg, 100 μg, 5 μg
  • LD78 beta/CCL3L1 Rabbit Polyclonal Antibody [orb184883]

    ICC,  IF,  IHC-Fr,  IHC-P

    Human

    Human

    Rabbit

    Polyclonal

    Unconjugated

    50 μl, 100 μl, 200 μl
  • CCL4 Antibody [orb1254051]

    ELISA,  WB

    Human

    Gallus

    Polyclonal

    Unconjugated

    0.05 mg
  • pat-2 Antibody [orb800579]

    ELISA,  WB

    Other

    Rabbit

    Polyclonal

    Unconjugated

    2 mg
  • Human MIP 1b Protein [orb427120]

    Greater than 99.0% as determined by:(a) Analysis by RP-HPLC.(b) Analysis by SDS-PAGE.

    Escherichia Coli

    2 μg, 10 μg, 1 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Protocol Information